Gilead Sciences

Member: Gold
Since: 17.03.2014

2, Rizountos & Thrakis Street, GR-167 77 Helliniko, Athens, Greece

RSS

07.10.2021

GILEAD: Launches Pharmaceutical Education Program to Increase Workplace Diversity
Last month, the company launched a first-of-its-kind educational partnership with Colleges, Universities and Institutions
23.02.2021

Gilead Sciences and Wake Forest University School of Divinity Partner to Address HIV Epidemic Through Faith-Based Programming and Community Outreach
Gilead Will Provide $5 Million in Grant Funding to Wake Forest Over 3 Years as Part of the Gilead COMPASS Initiative ® in the Southern United States
26.01.2021

Gilead: Francesco M. Marincola Joins Kite as Worldwide Head of Cell Therapy Research
Research Veteran Brings More than 30 Years of Industry and NIH Experience to Kite Leadership Team
14.09.2020

Gilead Ramps Up Cancer Focus With $21 Billion Immunomedics Deal
Another big bet by Gilead that an innovative tumor-fighting drug can boost its fortunes
31.08.2020

Gilead’s Investigational Antiviral Veklury® (Remdesivir) Receives U.S. Food and Drug Administration Emergency Use Authorization for the Treatment of Patients With Moderate COVID-19
Expands Previous Authorization of Veklury to Treat Hospitalized Patients with COVID-19 Regardless of Oxygen Status
MORE

CORPORATE